バーター症候群治療薬の世界市場（～2026年）

• 英文タイトル：Global Bartter Syndrome Drugs Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11021
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はバーター症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別バーター症候群治療薬の競争状況、市場シェア
・世界のバーター症候群治療薬市場：種類別市場規模 2015年-2020年（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、その他）
・世界のバーター症候群治療薬市場：種類別市場規模予測 2021年-2026年（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、その他）
・世界のバーター症候群治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局）
・世界のバーター症候群治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局）
・北米のバーター症候群治療薬市場分析：米国、カナダ
・ヨーロッパのバーター症候群治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのバーター症候群治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のバーター症候群治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのバーター症候群治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Abbott Laboratories、Novartis、Pfizer、Eli Lilly、Bristol-Myers Squibb
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function.

Market Analysis and Insights: Global Bartter Syndrome Drugs Market
The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Bartter Syndrome Drugs Scope and Market Size
Bartter Syndrome Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bartter Syndrome Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbott Laboratories
Novartis
Pfizer
Eli Lilly
Bristol-Myers Squibb
…

Market segment by Type, the product can be split into
NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
RAAS Inhibitors
Aldosterone Antagonists
Angiotensin II Receptor Blockers
Angiotensin-Converting Enzyme (ACE) Inhibitors
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bartter Syndrome Drugs Revenue
1.4 Market by Type
1.4.1 Global Bartter Syndrome Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
1.4.3 RAAS Inhibitors
1.4.4 Aldosterone Antagonists
1.4.5 Angiotensin II Receptor Blockers
1.4.6 Angiotensin-Converting Enzyme (ACE) Inhibitors
1.4.7 Others
1.5 Market by Application
1.5.1 Global Bartter Syndrome Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Bartter Syndrome Drugs Market Perspective (2015-2026)
2.2 Global Bartter Syndrome Drugs Growth Trends by Regions
2.2.1 Bartter Syndrome Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bartter Syndrome Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Bartter Syndrome Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bartter Syndrome Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Bartter Syndrome Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Bartter Syndrome Drugs Players by Market Size
3.1.1 Global Top Bartter Syndrome Drugs Players by Revenue (2015-2020)
3.1.2 Global Bartter Syndrome Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Bartter Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bartter Syndrome Drugs Market Concentration Ratio
3.2.1 Global Bartter Syndrome Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bartter Syndrome Drugs Revenue in 2019
3.3 Bartter Syndrome Drugs Key Players Head office and Area Served
3.4 Key Players Bartter Syndrome Drugs Product Solution and Service
3.5 Date of Enter into Bartter Syndrome Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Bartter Syndrome Drugs Historic Market Size by Type (2015-2020)
4.2 Global Bartter Syndrome Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Bartter Syndrome Drugs Market Size by Application (2015-2020)
5.2 Global Bartter Syndrome Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Bartter Syndrome Drugs Market Size (2015-2020)
6.2 Bartter Syndrome Drugs Key Players in North America (2019-2020)
6.3 North America Bartter Syndrome Drugs Market Size by Type (2015-2020)
6.4 North America Bartter Syndrome Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Bartter Syndrome Drugs Market Size (2015-2020)
7.2 Bartter Syndrome Drugs Key Players in Europe (2019-2020)
7.3 Europe Bartter Syndrome Drugs Market Size by Type (2015-2020)
7.4 Europe Bartter Syndrome Drugs Market Size by Application (2015-2020)

8 China
8.1 China Bartter Syndrome Drugs Market Size (2015-2020)
8.2 Bartter Syndrome Drugs Key Players in China (2019-2020)
8.3 China Bartter Syndrome Drugs Market Size by Type (2015-2020)
8.4 China Bartter Syndrome Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Bartter Syndrome Drugs Market Size (2015-2020)
9.2 Bartter Syndrome Drugs Key Players in Japan (2019-2020)
9.3 Japan Bartter Syndrome Drugs Market Size by Type (2015-2020)
9.4 Japan Bartter Syndrome Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Bartter Syndrome Drugs Market Size (2015-2020)
10.2 Bartter Syndrome Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bartter Syndrome Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Bartter Syndrome Drugs Market Size by Application (2015-2020)

11 India
11.1 India Bartter Syndrome Drugs Market Size (2015-2020)
11.2 Bartter Syndrome Drugs Key Players in India (2019-2020)
11.3 India Bartter Syndrome Drugs Market Size by Type (2015-2020)
11.4 India Bartter Syndrome Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Bartter Syndrome Drugs Market Size (2015-2020)
12.2 Bartter Syndrome Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Bartter Syndrome Drugs Market Size by Type (2015-2020)
12.4 Central & South America Bartter Syndrome Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Bartter Syndrome Drugs Introduction
13.1.4 Abbott Laboratories Revenue in Bartter Syndrome Drugs Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Bartter Syndrome Drugs Introduction
13.2.4 Novartis Revenue in Bartter Syndrome Drugs Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Bartter Syndrome Drugs Introduction
13.3.4 Pfizer Revenue in Bartter Syndrome Drugs Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Bartter Syndrome Drugs Introduction
13.4.4 Eli Lilly Revenue in Bartter Syndrome Drugs Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview
13.5.3 Bristol-Myers Squibb Bartter Syndrome Drugs Introduction
13.5.4 Bristol-Myers Squibb Revenue in Bartter Syndrome Drugs Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Bartter Syndrome Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Bartter Syndrome Drugs Revenue
Table 3. Ranking of Global Top Bartter Syndrome Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bartter Syndrome Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
Table 6. Key Players of RAAS Inhibitors
Table 7. Key Players of Aldosterone Antagonists
Table 8. Key Players of Angiotensin II Receptor Blockers
Table 9. Key Players of Angiotensin-Converting Enzyme (ACE) Inhibitors
Table 10. Key Players of Others
Table 11. Global Bartter Syndrome Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Bartter Syndrome Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Bartter Syndrome Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Bartter Syndrome Drugs Market Share by Regions (2015-2020)
Table 15. Global Bartter Syndrome Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Bartter Syndrome Drugs Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Bartter Syndrome Drugs Market Growth Strategy
Table 21. Main Points Interviewed from Key Bartter Syndrome Drugs Players
Table 22. Global Bartter Syndrome Drugs Revenue by Players (2015-2020) (Million US$)
Table 23. Global Bartter Syndrome Drugs Market Share by Players (2015-2020)
Table 24. Global Top Bartter Syndrome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bartter Syndrome Drugs as of 2019)
Table 25. Global Bartter Syndrome Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Bartter Syndrome Drugs Product Solution and Service
Table 28. Date of Enter into Bartter Syndrome Drugs Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Bartter Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 31. Global Bartter Syndrome Drugs Market Size Share by Type (2015-2020)
Table 32. Global Bartter Syndrome Drugs Revenue Market Share by Type (2021-2026)
Table 33. Global Bartter Syndrome Drugs Market Size Share by Application (2015-2020)
Table 34. Global Bartter Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 35. Global Bartter Syndrome Drugs Market Size Share by Application (2021-2026)
Table 36. North America Key Players Bartter Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Bartter Syndrome Drugs Market Share (2019-2020)
Table 38. North America Bartter Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 39. North America Bartter Syndrome Drugs Market Share by Type (2015-2020)
Table 40. North America Bartter Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 41. North America Bartter Syndrome Drugs Market Share by Application (2015-2020)
Table 42. Europe Key Players Bartter Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Bartter Syndrome Drugs Market Share (2019-2020)
Table 44. Europe Bartter Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Bartter Syndrome Drugs Market Share by Type (2015-2020)
Table 46. Europe Bartter Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Bartter Syndrome Drugs Market Share by Application (2015-2020)
Table 48. China Key Players Bartter Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 49. China Key Players Bartter Syndrome Drugs Market Share (2019-2020)
Table 50. China Bartter Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 51. China Bartter Syndrome Drugs Market Share by Type (2015-2020)
Table 52. China Bartter Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 53. China Bartter Syndrome Drugs Market Share by Application (2015-2020)
Table 54. Japan Key Players Bartter Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Bartter Syndrome Drugs Market Share (2019-2020)
Table 56. Japan Bartter Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Bartter Syndrome Drugs Market Share by Type (2015-2020)
Table 58. Japan Bartter Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Bartter Syndrome Drugs Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Bartter Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Bartter Syndrome Drugs Market Share (2019-2020)
Table 62. Southeast Asia Bartter Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Bartter Syndrome Drugs Market Share by Type (2015-2020)
Table 64. Southeast Asia Bartter Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Bartter Syndrome Drugs Market Share by Application (2015-2020)
Table 66. India Key Players Bartter Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 67. India Key Players Bartter Syndrome Drugs Market Share (2019-2020)
Table 68. India Bartter Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 69. India Bartter Syndrome Drugs Market Share by Type (2015-2020)
Table 70. India Bartter Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 71. India Bartter Syndrome Drugs Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Bartter Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Bartter Syndrome Drugs Market Share (2019-2020)
Table 74. Central & South America Bartter Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Bartter Syndrome Drugs Market Share by Type (2015-2020)
Table 76. Central & South America Bartter Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Bartter Syndrome Drugs Market Share by Application (2015-2020)
Table 78. Abbott Laboratories Company Details
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Product
Table 81. Abbott Laboratories Revenue in Bartter Syndrome Drugs Business (2015-2020) (Million US$)
Table 82. Abbott Laboratories Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Product
Table 86. Novartis Revenue in Bartter Syndrome Drugs Business (2015-2020) (Million US$)
Table 87. Novartis Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Product
Table 91. Pfizer Revenue in Bartter Syndrome Drugs Business (2015-2020) (Million US$)
Table 92. Pfizer Recent Development
Table 93. Eli Lilly Company Details
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Product
Table 96. Eli Lilly Revenue in Bartter Syndrome Drugs Business (2015-2020) (Million US$)
Table 97. Eli Lilly Recent Development
Table 98. Bristol-Myers Squibb Company Details
Table 99. Bristol-Myers Squibb Business Overview
Table 100. Bristol-Myers Squibb Product
Table 101. Bristol-Myers Squibb Revenue in Bartter Syndrome Drugs Business (2015-2020) (Million US$)
Table 102. Bristol-Myers Squibb Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bartter Syndrome Drugs Market Share by Type: 2020 VS 2026
Figure 2. NSAIDs (Nonsteroidal Anti-inflammatory Drugs) Features
Figure 3. RAAS Inhibitors Features
Figure 4. Aldosterone Antagonists Features
Figure 5. Angiotensin II Receptor Blockers Features
Figure 6. Angiotensin-Converting Enzyme (ACE) Inhibitors Features
Figure 7. Others Features
Figure 8. Global Bartter Syndrome Drugs Market Share by Application: 2020 VS 2026
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Bartter Syndrome Drugs Report Years Considered
Figure 13. Global Bartter Syndrome Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Bartter Syndrome Drugs Market Share by Regions: 2020 VS 2026
Figure 15. Global Bartter Syndrome Drugs Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Bartter Syndrome Drugs Market Share by Players in 2019
Figure 18. Global Top Bartter Syndrome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bartter Syndrome Drugs as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Bartter Syndrome Drugs Revenue in 2019
Figure 20. North America Bartter Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Bartter Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Bartter Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Bartter Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Bartter Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Bartter Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Bartter Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed

以下、関連資料のご紹介

バーター症候群治療の世界市場（～2026年）

Global Bartter Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11022 2020年11月25日 96Pages
当調査資料はバーター症候群治療のグローバル市場について調査・分析したレポートです。種類別（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬...

アスペルガー症候群治療薬の世界市場（～2026年）

Global Asperger Syndrome Drugs Market Size, Status and Forecast 2020-2026
MRC2-11QY10909 2020年11月25日 91Pages
当調査資料はアスペルガー症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（抗精神病薬、選択的セロトニン再取り込み阻害薬、精神科薬、その他）市場規模、用途別（病院、クリニック、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

ギランバレー症候群治療薬の世界市場（～2026年）

Global Guillain-Barre Syndrome Drugs Market Insights and Forecast to 2026
MRC2-11QY07010 2020年11月20日 112Pages
当調査資料はギランバレー症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（余矢、免疫グロブリン、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

短腸症候群（SBS）治療薬の世界市場（～2026年）

Global Short Bowel Syndrome (SBS) Drugs Market Insights and Forecast to 2026
MRC2-11QY09456 2020年11月25日 112Pages
当調査資料は短腸症候群（SBS）治療薬のグローバル市場について調査・分析したレポートです。種類別（グルカゴン様ペプチド-2（GLP-2）、成長ホルモン、グルタミン、その他）市場規模、用途別（病院、診療所、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

セロトニン症候群の世界市場（～2026年）

Global Serotonin Syndrome Market Size, Status and Forecast 2020-2026
MRC2-11QY04588 2020年11月20日 95Pages
当調査資料はセロトニン症候群のグローバル市場について調査・分析したレポートです。種類別（セロトニン拮抗薬、支持療法、胃腸浄化、その他）市場規模、用途別（病院用、診療所用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...

多嚢胞性卵巣症候群（PCOS）治療薬の世界市場（～2026年）

Global Polycystic Ovary Syndrome (PCOS) Drugs Market Insights and Forecast to 2026
MRC2-11QY13974 2020年11月30日 114Pages
当調査資料は多嚢胞性卵巣症候群（PCOS）治療薬のグローバル市場について調査・分析したレポートです。種類別（経口避妊薬、抗アンドロゲン剤、インスリン感作剤、抗うつ剤、抗肥満剤）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

間欠的発熱症候群の世界市場（～2026年）

Global Periodic Fever Syndrome Market Size, Status and Forecast 2020-2026
MRC2-11QY04216 2020年11月20日 98Pages
当調査資料は間欠的発熱症候群のグローバル市場について調査・分析したレポートです。種類別（高IGE D症候群、家族性地中海熱症候群、TNF受容体関連周期症候群、クリオピリン関連周期症候群、その他）市場規模、用途別（病院、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

ドライアイ症候群の世界市場（～2026年）

Global Dry Eye Syndrome Market Insights and Forecast to 2026
MRC2-11QY05451 2020年11月20日 117Pages
当調査資料はドライアイ症候群のグローバル市場について調査・分析したレポートです。種類別（処方薬、店頭（OTC）薬）市場規模、用途別（病院・診療所、臨床検査室、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

吸収不良症候群の世界市場（～2026年）

Global Malabsorption Syndrome Market Size, Status and Forecast 2020-2026
MRC2-11QY12575 2020年11月25日 93Pages
当調査資料は吸収不良症候群のグローバル市場について調査・分析したレポートです。種類別（乳糖不耐症、嚢胞性線維症、ウィップル病、寄生虫症、熱帯性スプルー、腸障害）市場規模、用途別（製薬会社、病院、栄養クリニック、学術研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

ドラベ症候群治療の世界市場（～2026年）

Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11711 2020年11月25日 97Pages
当調査資料はドラベ症候群治療のグローバル市場について調査・分析したレポートです。種類別（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））市場規模、用途別（病院薬局、小売薬局、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
アスペルガー症候群治療薬の世界市場（～2026年） The Asperger syndrome is a type of developmental disorders known as Autistic Spectrum Disorder (ASD). These disorders initiate in childhood and stay with individuals until their adult life. Children with the Asperger syndrome function better than those with autism, and they have normal intelligence …
ギランバレー症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Guillain-Barre Syndrome Drugs Market The global Guillain-Barre Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Guillain-Barre Syndrome Drugs Scope and Market Size Gui…
抗高血圧薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-Hypertensive Drugs Market The global Anti-Hypertensive Drugs market size is projected to reach US$ 40970 million by 2026, from US$ 40270 million in 2020, at a CAGR of 1.6%% during 2021-2026. Global Anti-Hypertensive Drugs Scope and Market Size Anti-Hypertens…